(Press-News.org) CHD5 has previously been proposed as a tumour suppressor, acting as a brake that prevents healthy cells from developing into cancer cells. But the part played by the protein in healthy tissue, and whether this role is important for its ability to counter tumour growth, has remained largely uncharted. Working with colleagues at Trinity College in Dublin and BRIC in Copenhagen, researchers at Karolinska Institutet have revealed its function in normal nervous system development and as a tumour suppressor.
The recently published study shows that when stem cells approach the final phase of their specialisation as neurons, CHD5 begins to be expressed at high levels. CHD5 can reshape the chromatin, in which DNA is packed around proteins, and in so doing either facilitate or obstruct the expression of genes. Ulrika Nyman, postdoc researcher in Dr Johan Holmberg's research group and one of the main authors of the current study, explains that on switching off CHD5 in the stem cells of mice embryos during the period in which the brain develops and the majority of neurons are formed, they found was that without CHD5, a stem cell is unable to silence the expression of a number of stem cell genes and genes that are actually to be expressed in muscle, blood or intestinal cells. They also observed an inability in the stem cell to switch on the expression of genes necessary for it to mature into a neuron, leaving it trapped in a stage between stem cell and neuron.
The gene that codes for CHD5 is found on part of chromosome 1 (1p36), which is often lost in tumour cells in a number of cancers, particularly neuroblastoma, a disease that strikes almost only children and which is thought to arise during the development of the peripheral nervous system. Neuroblastoma lacking this section of chromosome and thus also CHD5 are often more aggressive and more rapidly fatal. Treatment with retinoic acid can make immature nerve cells and some neuroblastoma cells mature into specialised nerve cells, but when the researchers prevented neuroblastoma cells from upregulating CHD5, the tumours no longer responded to retinoic acid treatment.
"In the absence of CHD5, neural tumour cells cannot mature into harmless neurons, but continue to divide, making the tumour more malignant and much harder to treat," says Dr Holmberg at the Department of Cell and Molecular Biology. "We now hope to be able to restore the ability to upregulate CHD5 in aggressive tumour cells and make them mature into harmless nerve cells."
###
The research group at Karolinska Institutet is also active at the Ludwig Institute for Cancer Research. The study was financed by grants from the Swedish Research Council, the Swedish Cancer Society, the Children's Cancer Foundation and the Lilian Sagen and Curt Eriksson Research Foundation.
Publication: Egan et al., CHD5 Is Required for Neurogenesis and Has a Dual Role in Facilitating Gene Expression and Polycomb Gene Repression, Developmental Cell (2013), http://dx.doi.org/10.1016/j.devcel.2013.07.008
For further information, contact:
Johan Holmberg, research associate
Department of Cell and Molecular Biology & the Ludwig Institute for Cancer Research
Tel: +46 (0)8 524 871 08 or +46 (0)72 221 27 02
Email: Johan.Holmberg@ki.se
Contact the Press Office
Tel: +46 (0)8 524 860 77
Email: pressinfo@ki.se
Karolinska Institutet is one of the world's leading medical universities. It accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country's broadest range of education in medicine and health sciences. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine.
Tumor suppressor is needed for stem cells to mature into neurons
2013-08-12
ELSE PRESS RELEASES FROM THIS DATE:
Carnegie Mellon researchers say readers' identities can reveal much about content of articles
2013-08-12
PITTSBURGH -- Articles that people share on social networks can reveal a lot about those readers, research has shown. But a new Carnegie Mellon University study reverses the proposition, asking the question: What can be learned about an article from the attributes of its readers?
To find out, the CMU researchers, along with colleagues at the University of Washington, analyzed almost 3 million news articles and the public profiles of the people who shared those articles on Twitter. This enabled them to generate a few thousand "badges" that characterized the content of ...
Rice writes rules for gene-therapy vectors
2013-08-12
HOUSTON -- Rice University researchers are making strides toward a set of rules to custom-design Lego-like viral capsid proteins for gene therapy.
A new paper by Rice scientists Junghae Suh and Jonathan Silberg and their students details their use of computational and bioengineering methods to combine pieces of very different adeno-associated viruses (AAVs) to create new, benign viruses that can deliver DNA payloads to specific cells.
The research appears this month in the American Chemical Society journal ACS Synthetic Biology.
AAVs are found in nature and commonly ...
Onsite colposcopy clinic improves cancer screening rates: Study
2013-08-12
TORONTO, ON, August 12, 2013 – Women who had a colposcopy at a sexual health clinic that provided extra support and counselling were 34 per cent more likely to undergo the cancer screening procedure compared to women who were referred to a hospital or doctor's office, according to a new study by Women's College Hospital's Dr. Sheila Dunn.
Although colposcopy is an important component of cervical cancer screening, some women, particularly those who are disadvantaged, fail to attend colposcopy appointments. However, researchers in the study, published today in the Journal ...
Mayo Clinic: Preclinical tests may lead to new approach to treat CNS lymphoma
2013-08-12
JACKSONVILLE, Fla. -- A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes. The clinical trial, now open at the three campuses of Mayo Clinic -- in Florida, Minnesota and Arizona -- follows successful testing of the drug, pomalidomide, in mouse models of CNS lymphoma. Details of the preclinical testing are available in the science journal PLOS ONE.
Approximately 5,000 patients are diagnosed ...
Communicating nightingales: Older males trill better
2013-08-12
Older male nightingales perform faster and more demanding trills than their younger rivals. These findings were published by researchers at the University of Basel and the Netherlands Institute of Ecology in the online edition of Journal of Avian Biology. With up to 100 trill elements a second, nightingales belong to the fastest singers.
Nightingales are famous for their large song repertoire: Each male can perform around 200 different song types. Facing this great variety, how can a female listener assess correctly if the male counterpart is a suitable mating partner? ...
Competition changes how people view strangers online
2013-08-12
COLUMBUS, Ohio -- An anonymous stranger you encounter on websites like Yelp or Amazon may seem to be just like you, and a potential friend. But a stranger on a site like eBay is a whole different story.
A new study finds that on websites where people compete against each other, assumptions about strangers change.
Previous research has shown that people have a bias toward thinking that strangers they encounter online are probably just like them.
But when they are competitors, strangers are seen as different, and not sharing your traits and values -- and that changes ...
New materials for bio-based hydrogen synthesis
2013-08-12
Researchers at the Ruhr-Universität Bochum (RUB) have discovered an efficient process for hydrogen biocatalysis. They developed semi-synthetic hydrogenases, hydrogen-generating enzymes, by adding the protein's biological precursor to a chemically synthesized inactive iron complex. From these two components, the biological catalyst formed spontaneously in a test tube. "Extracting hydrogenases from living cells is highly difficult," says Prof Dr Thomas Happe, head of the work group Photobiotechnology at the RUB. "Therefore, their industrial application has always been a long ...
Simulating flow from volcanoes and oil spills
2013-08-12
WASHINGTON D.C. August 12, 2013 -- Some time around 37,000 BCE a massive volcano erupted in the Campanian region of Italy, blanketing much of Europe with ash, stunting plant growth and possibly dooming the Neanderthals. While our prehistoric relatives had no way to know the ash cloud was coming, a recent study provides a new tool that may have predicted what path volcanic debris would take.
"This paper provides a model for the pattern of the ash cloud if the wind is blowing past an eruption of a given size," said Peter Baines, a scientist at the University of Melbourne ...
Scientists develop method that ensures safe research on deadly flu viruses
2013-08-12
A new strategy that dismantles a viral genome in human lung cells will ensure safe research on deadly strains of influenza, say researchers from the Icahn School of Medicine at Mount Sinai.
Details of their "molecular biocontainment" approach, designed to prevent effective transmission of these viruses to humans, are published in Nature Biotechnology.
The strategy they developed and tested will enable healthy molecules in human lung cells to latch on to these viruses and cut the bugs up before they have a chance to infect the human host.
Findings from the study, ...
Expert: Taxation of retirement income in need of reform
2013-08-12
CHAMPAIGN, Ill. — Although planning for a comfortable retirement is a mainstay of public discussion, far less attention has been paid to the tax consequences of generating retirement income, says a University of Illinois expert on taxation and retirement benefits.
According to law professor Richard L. Kaplan, the income tax consequences for retirees are varied, outdated or often outright inappropriate.
"Legal and financial analyses abound regarding the various means of saving for retirement and the tax advantages that each option presents, but very few people consider ...